The Maharashtra Food and Drug Administration (FDA) issues a compliance order restricting how infant formula is promoted. The order prohibits advertising infant formula through any medium, including social media and e-commerce, and also bars giveaways linked to promotions. It also requires manufacturers and sellers to follow prescribed instructions and labeling guidelines related to infant nutrition.
The FDA states that violations will attract financial penalties, with reports citing fines up to Rs 10 lakh. The order also directs manufacturers to maintain traceability systems and ensure compliance with standards for product information. While the core focus is the same across outlets, coverage emphasizes different aspects of enforcement: one highlights the breadth of the advertising ban across digital platforms, while another underscores the inclusion of influencer advertising within the restrictions.
Overall, the action reflects tighter regulatory oversight of infant nutrition marketing in Maharashtra, with companies expected to adjust labeling and marketing practices to align with the FDA’s rules and avoid penalties for non-compliance.
